Published · April 25, 2026· Updated September 16, 2026

Key Clinical Trial Terms

Clinical Trial Phase

What do Phase 1, 2, 3, and 4 actually mean?

The stages of testing a drug: Phase 1 (Safety and dosing), Phase 2 (Preliminary efficacy and dosing in patients), Phase 3 (Comparison to standard treatment in large groups), and Phase 4 (Long-term monitoring after approval).

Read more: What is a Clinical Trial?

See also: Phase 1, Phase 2, Phase 3, Phase 4

Phase 1

Is Phase 1 only for healthy volunteers, and what is it testing?

An early phase focused mainly on safety, dosing, and what the body does to the drug — not on proving that the treatment works. In oncology and some other fields, participants are usually patients, not generally healthy volunteers.

Read more: What is a Clinical Trial?

Phase 2

Is Phase 2 still experimental, or is it already proving the drug works?

The stage of a clinical trial that tests whether a treatment shows promise in patients with a specific disease. Researchers look for preliminary efficacy while continuing to monitor safety and refine dosing. Meaningful benefit is often first observed here, years before a drug is widely available.

Read more: What is a Clinical Trial?

See also: Phase 1, Phase 3, MTD and RP2D

Phase 3

Why does a Phase 3 trial matter for patients?

The large confirmatory stage of a clinical trial, usually comparing the new treatment with the current standard of care. A positive Phase 3 result is typically the last major clinical hurdle before companies seek regulatory approval, though approval, pricing, and availability can still take years.

Read more: What is a Clinical Trial?

See also: Phase 2, Phase 4, Active Comparator

Phase 4

If the treatment is already approved, why is there still a Phase 4 study?

A post-approval study that looks at safety, effectiveness, and real-world use over longer periods and in broader groups of people than the earlier trials.

Read more: What is a Clinical Trial?

First-in-Human (FIH)

What does “first-in-human” mean for the people who join?

The first time a treatment is given to humans. It is usually a small, cautious study focused on safety and dosing.

Read more: What is a Clinical Trial?

NCT Number

What is an NCT number, and why should I write it down?

A unique identification number assigned to each clinical trial (e.g., NCT01234567). It serves as the "ID card" for the study in global databases.

Recruiting

Does “recruiting” mean I can still join this trial?

The status indicating that a clinical trial is currently open and looking for new participants to join.

Enrollment, Estimated vs Actual

The study lists only a small number of people. Is that a red flag?

How many people the study plans to recruit, and how many were actually recruited. A small number is not necessarily a problem, especially in a rare disease, where there simply are not many eligible patients.

Protocol

When the team says “the protocol,” what are they talking about?

The detailed plan that describes how a clinical trial will be conducted, including treatment dosing, visit schedule, tests, and procedures. When doctors say "the protocol," they are referring to this plan.

Protocol Amendment

Can the study plan change after I have already joined?

A formal change to the study plan — for example dosing, eligibility, or the visit schedule. Amendments need the right review and approval, and you should be told if the change affects you.

Protocol Deviation

What if something in my care did not follow the study plan exactly?

When the study did not run exactly as planned for a participant or a site. Not every deviation puts the patient in danger, but it is documented and reviewed.

Interventional vs Observational Study

Will researchers assign me a treatment, or only follow what already happens?

In an interventional study, researchers assign a treatment or strategy. In an observational study, they only follow people and collect data, without dictating which treatment you get.

Read more: What is a Clinical Trial?

Investigational Treatment / Investigational Product

Does “investigational” mean the drug is completely unapproved?

A drug, device, or treatment being studied and not yet approved for the use under investigation — even if it is already approved for another purpose.

Primary & Secondary Outcome Measures

What is the trial actually measuring, and which result counts most?

The results the study is designed to measure. On a ClinicalTrials.gov record these appear as primary and secondary outcome measures. The primary measure is the main question the trial must answer; secondary measures add more detail, such as safety or quality of life. They describe what researchers will look at — not a promise of what will happen to you.

Principal Investigator (PI)

Who is actually in charge of the trial at my hospital?

The lead doctor responsible for conducting and overseeing the clinical trial at a specific medical site.

Read more: What is a Clinical Trial?

Institutional Review Board (IRB) / Ethics Committee

Who checks that this study is fair and that the consent form tells the truth?

An independent body that reviews and approves the study and the consent form to protect participants' rights and welfare. In Israel this is often called a Helsinki Committee. If a team cannot say which committee approved the study, that is a reason to pause.

Data and Safety Monitoring Board (DSMB/DMC)

Is anyone looking at the results while the study is still running?

A group that reviews safety and efficacy data during the study and can recommend changing, pausing, stopping, or continuing it.

Standard of Care (SOC)

If I am not in the experimental group, what treatment do I get?

The current best accepted treatment for the disease by the medical community. In many trials, the control group receives this standard treatment.

Line of Therapy

Why does the listing ask whether I already had a first or second line of therapy?

Many trials require a patient to have completed a "first" or "second" line of therapy. This refers to the main treatments the patient has already received for their disease, which directly affects their eligibility for a trial.

Biomarkers & Mutations

Why do some trials only accept people with a specific mutation or test result?

Terms like EGFR, BRCA, or protein expression. Many modern trials require a specific molecular profile of the tumor. Therefore, it's important for patients to ask their doctor for genetic sequencing to find trials tailored to their specific biology.

Personalized Medicine

Is this treatment built for my disease specifically, or for everyone with the same diagnosis?

An approach to treatment tailored to an individual patient, often using genetic or molecular information from their disease. A personalized mRNA cancer vaccine is one example: it is built from the unique mutations in that patient's tumor rather than using a one-size-fits-all shot.

Inclusion Criteria

What must be true about me for this trial to even consider me?

The rules that decide who can join a trial. "Inclusion criteria" are the things you must have (like a specific diagnosis).

Exclusion Criteria

What would automatically keep me out of this trial?

"Exclusion criteria" are factors that disqualify someone (like certain past treatments or health conditions) to ensure patient safety.

Eligibility

How do they decide whether I “fit” the study?

The overall status of whether a patient fits the study protocol based on the inclusion and exclusion criteria.

Washout Period

Why might I have to wait after stopping my current treatment?

The required time that must pass between finishing a previous treatment and starting the experimental one, allowing the body to "clear" the old drug and prevent unwanted interactions.

Screening Phase

I said I am interested. What happens before I actually start treatment?

The initial period of a few weeks after you express interest, where you undergo blood tests, scans, and check-ups. This is done to safely confirm that you perfectly meet all the trial's requirements before you start receiving the treatment.

Concomitant and Rescue Medication

Can I keep taking my other medicines, and what if symptoms get out of control?

Which medications you may or may not take alongside the study treatment, and what the team is allowed to give if symptoms are not controlled. Ask for the list in writing before you join.

Randomization

Can my doctor choose which group I go into?

The process of assigning patients to different groups in a trial. This is done by a computer program (like flipping a coin), not by the doctor, to prevent bias in the research.

Study Arm

What is a study arm, and how does it affect the treatment I might get?

A group within the trial that receives a specific treatment or strategy. The arms are the key to understanding your chance of getting each treatment and what the study is actually comparing.

Experimental Arm

Which group is getting the new treatment being tested?

The group receiving the new treatment being tested, either on its own or together with another treatment.

Active Comparator

If I am not getting the new drug, am I getting nothing?

An active, accepted treatment used for comparison, as opposed to placebo or no treatment.

Cohort

Why does the listing mention different cohorts?

A group of participants in a clinical trial who share similar medical characteristics.

Crossover Design

If I start in the control group, will I later get the experimental treatment?

A study design in which each participant receives more than one intervention in a planned order, across different periods of the study, so groups can be compared over those periods. That is not the same as being allowed to switch from the control group to the experimental treatment after the disease gets worse. Some trials offer that kind of treatment switch, but many do not, and it is never guaranteed. Ask the team what this protocol actually allows.

Placebo (and Control Group)

Could I get a sugar pill instead of real treatment?

The control group is the group to which the new treatment is compared. It's important to know that in oncology and many severe diseases, the control group rarely gets a "sugar pill" (placebo); instead, they receive the best standard treatment currently available.

Open-Label

Does open-label mean everyone knows which treatment I am getting?

A clinical trial where both the doctor and the patient know exactly which treatment the patient is receiving (as opposed to a double-blind trial where this is hidden).

Dose Escalation

Why do later groups in an early trial get a higher dose than the first group?

An early part of a study where successive groups receive higher doses to find a dose that is safe and suitable to continue with.

Dose-Limiting Toxicity (DLT)

What would stop the team from raising the dose any further?

A side effect that is severe enough, under the study rules, to block a higher dose or to require a lower one.

MTD and RP2D

Is the highest tolerated dose always the dose they take forward?

MTD is the highest dose tolerated under the study rules. RP2D is the dose chosen for the next stage. The two are not always the same: a slightly lower dose may be chosen if it looks safer or more practical.

Pharmacokinetics (PK)

Why do they keep drawing blood after each dose?

What the body does to the drug: how it is absorbed, distributed, broken down, and cleared over time.

Pharmacodynamics (PD)

How do researchers tell whether the drug is actually doing something in my body?

What the drug does to the body or the disease — for example a change in a biomarker or in the activity of a molecular pathway. This is not the same as PK, which tracks the drug itself in the body.

Progression-Free Survival (PFS)

Does “progression-free survival” mean the trial is measuring how long I will live?

A common goal measured in trials, especially in oncology. Despite the word "survival," it simply measures how long the treatment successfully keeps the disease stable, quiet, or from growing, even if the tumor doesn't disappear completely.

Overall Survival (OS)

How is overall survival different from PFS?

The time from a defined starting point in the study until death from any cause. It is different from PFS, which measures time without the disease getting worse.

Objective Response Rate (ORR)

What does it mean if a trial reports an “objective response rate”?

The proportion of patients whose tumor shrinks by a defined amount, usually a complete or partial response.

CR, PR, SD, PD

What do CR, PR, SD, and PD mean on a scan report?

The four common tumor-assessment outcomes, using defined rules: complete response (the target disease is no longer seen), partial response (shrinkage), stable disease, or progressive disease (growth or worsening).

Duration of Response (DoR)

If the tumor shrinks, how long does that response have to last to “count”?

How long a response to treatment lasts, from the first time it is documented until the disease progresses, or until another time point defined in the protocol.

RECIST

How do they decide from scans whether my cancer got better, stayed the same, or got worse?

The standard rule set for measuring change in solid tumors on scans and for defining complete response, partial response, stable disease, or progressive disease.

Patient-Reported Outcomes (PROs)

Why do they keep giving me questionnaires instead of just looking at the labs?

Questionnaires where patients themselves report symptoms, function, and quality of life, without the staff interpreting those answers first.

Performance Status (ECOG)

Why does a score about walking and daily activity decide if I can join?

A score (0 to 5) measuring how well a patient can carry out daily activities. Most trials require an ECOG score of 0 or 1, meaning the patient is fully active or restricted in strenuous activity but can still walk and carry out light work. This is one of the most common reasons patients are found ineligible for trials.

Adverse Event (AE)

If something goes wrong during the trial, does that automatically mean the treatment caused it?

Any unwanted medical problem that happens during the study, whether or not it was caused by the treatment. Researchers call this an adverse event (AE). A "side effect" is a narrower idea: a problem thought to be caused by the treatment. So an AE is not automatically a side effect. People often search for "side effect" when they mean this term.

Serious Adverse Event (SAE)

What makes an adverse event “serious” — how bad it feels, or what happened next?

An event that leads to outcomes such as hospitalization, a life-threatening situation, significant disability, or death. "Serious" describes the medical outcome, not necessarily how intense the symptom felt, and not necessarily a proven link to the treatment.

Adverse Event Grade (CTCAE)

What does it mean if the team says a side effect was “grade 3”?

A scale, usually 1 to 5 in oncology (often CTCAE), that describes severity from mild symptoms to death related to the event.

Treatment Discontinuation vs Study Withdrawal

If I stop the study drug, do I have to leave the trial completely?

You can stop the study treatment and still stay in follow-up. Full withdrawal from the study is a separate decision, and it is always the participant's right.

Follow-Up Period

Why might they still call me months after the last dose?

The period after treatment ends during which safety, outcomes, and survival continue to be monitored, sometimes for months or years.

Compassionate Use (Expanded Access)

If I cannot join the trial, is there still a way to get the experimental treatment?

An option sometimes available for patients who don't meet the strict criteria of a clinical trial but urgently need treatment and may benefit from the experimental drug.

Basket Trial

Can one trial include different cancers if they share the same mutation?

A trial that tests a drug on patients with different types of cancer that share a common genetic mutation or biomarker. Instead of focusing on where the cancer is located, it focuses on what drives it genetically.

Umbrella Trial and Platform Trial

How is an umbrella or platform trial different from a usual one-drug study?

An umbrella trial tests different treatments in the same disease, often according to different biomarkers. A platform trial uses one shared infrastructure and can add or remove arms over time.

Natural History Study

Why would I join a study that is not testing any treatment?

An observational study that tracks how a disease progresses over time in patients, without testing any treatment. These studies are especially important in rare diseases, where being enrolled can put patients first in line for future treatment trials.

Clinical Trial Phase

Phase 1

Phase 2

Phase 3

Phase 4

First-in-Human (FIH)

NCT Number

Recruiting

Enrollment, Estimated vs Actual

Protocol

Protocol Amendment

Protocol Deviation

Interventional vs Observational Study

Investigational Treatment / Investigational Product

Primary & Secondary Outcome Measures

Principal Investigator (PI)

Sponsor

Institutional Review Board (IRB) / Ethics Committee

Data and Safety Monitoring Board (DSMB/DMC)

Standard of Care (SOC)

Line of Therapy

Biomarkers & Mutations

Personalized Medicine

Inclusion Criteria

Exclusion Criteria

Eligibility

Informed Consent

Washout Period

Screening Phase

Concomitant and Rescue Medication

Randomization

Study Arm

Experimental Arm

Active Comparator

Cohort

Crossover Design

Placebo (and Control Group)

Single-Blind and Masking

Double-Blind

Open-Label

Dose Escalation

Dose-Limiting Toxicity (DLT)

MTD and RP2D

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Progression-Free Survival (PFS)

Overall Survival (OS)

Objective Response Rate (ORR)

CR, PR, SD, PD

Duration of Response (DoR)

RECIST

Health-Related Quality of Life (HRQoL)

Patient-Reported Outcomes (PROs)

Performance Status (ECOG)

Adverse Event (AE)

Serious Adverse Event (SAE)

Adverse Event Grade (CTCAE)

Treatment Discontinuation vs Study Withdrawal

Follow-Up Period

Compassionate Use (Expanded Access)

Basket Trial

Umbrella Trial and Platform Trial

Natural History Study

Related conditions

Further reading

Looking for a clinical trial?